225 related articles for article (PubMed ID: 18780604)
41. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
[TBL] [Abstract][Full Text] [Related]
42. Influence of gender on serum growth hormone, insulin-like growth factor-I and its binding protein-3 during aging.
Lin CM; Huang YL; Lin ZY
Yonsei Med J; 2009 Jun; 50(3):407-13. PubMed ID: 19568604
[TBL] [Abstract][Full Text] [Related]
43. Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood.
Ong K; Kratzsch J; Kiess W; Costello M; Scott C; Dunger D
J Clin Endocrinol Metab; 2000 Nov; 85(11):4266-9. PubMed ID: 11095465
[TBL] [Abstract][Full Text] [Related]
44. Impact of insulin resistance on insulin-like growth factor-1/insulin like growth factor-binding protein-3 axis and on early weight gain in small for gestational age infants.
Dizdarer C; Korkmaz HA; Büyükocak ÖM; Tarancı SM; Coban A
J Clin Res Pediatr Endocrinol; 2013; 5(2):104-9. PubMed ID: 23748063
[TBL] [Abstract][Full Text] [Related]
45. Growth hormone, insulin like growth factor-1, and insulin-like growth factor-binding protein-3 levels in the neonatal period: a preliminary study.
Kurtoğlu S; Kondolot M; Mazicioğlu MM; Hatipoğlu N; Akin MA; Akyildiz B
J Pediatr Endocrinol Metab; 2010 Sep; 23(9):885-9. PubMed ID: 21175087
[TBL] [Abstract][Full Text] [Related]
46. The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group.
Dall R; Longobardi S; Ehrnborg C; Keay N; Rosén T; Jørgensen JO; Cuneo RC; Boroujerdi MA; Cittadini A; Napoli R; Christiansen JS; Bengtsson BA; Sacca L; Baxter RC; Basset EE; Sönksen PH
J Clin Endocrinol Metab; 2000 Nov; 85(11):4193-200. PubMed ID: 11095453
[TBL] [Abstract][Full Text] [Related]
47. Thyroid hormone modulates insulin-like growth factor-I(IGF-I) and IGF-binding protein-3, without mediation by growth hormone, in patients with autoimmune thyroid diseases.
Inukai T; Takanashi K; Takebayashi K; Fujiwara Y; Tayama K; Takemura Y
Horm Metab Res; 1999 Oct; 31(10):576-9. PubMed ID: 10596968
[TBL] [Abstract][Full Text] [Related]
48. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
Thorén M; Hilding A; Baxter RC; Degerblad M; Wivall-Helleryd IL; Hall K
J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of the auxological and metabolic status in prepubertal children born small for gestational age.
Toumba M; Hadjidemetriou A; Topouzi M; Savva SC; Demetriadou R; Kanaris C; Skordis N
J Pediatr Endocrinol Metab; 2005 Jul; 18(7):677-88. PubMed ID: 16128245
[TBL] [Abstract][Full Text] [Related]
50. Changes in serum concentrations of growth hormone, insulin, insulin-like growth factor and insulin-like growth factor-binding proteins 1 and 3 and urinary growth hormone excretion during the menstrual cycle.
Juul A; Scheike T; Pedersen AT; Main KM; Andersson AM; Pedersen LM; Skakkebaek NE
Hum Reprod; 1997 Oct; 12(10):2123-8. PubMed ID: 9402266
[TBL] [Abstract][Full Text] [Related]
51. Insulin-like Growth Factor I and its binding protein 3 in sepsis.
Papastathi C; Mavrommatis A; Mentzelopoulos S; Konstandelou E; Alevizaki M; Zakynthinos S
Growth Horm IGF Res; 2013 Aug; 23(4):98-104. PubMed ID: 23611528
[TBL] [Abstract][Full Text] [Related]
52. [Relationship of plasma ghrelin, IGF-1 and insulin with the growth and development of 2 -7 year-old children with small for gestational age at birth].
Cheng Y; Song G; Zhou L; Cai B; Zhao X; Yin J
Wei Sheng Yan Jiu; 2012 Jan; 41(1):18-22. PubMed ID: 22443052
[TBL] [Abstract][Full Text] [Related]
53. Growth factors and intrauterine growth retardation. II. Serum growth hormone, insulin-like growth factor (IGF) I, and IGF-binding protein 3 levels in children with intrauterine growth retardation compared with normal control subjects: prospective study from birth to two years of age. Study Group of IUGR.
Leger J; Noel M; Limal JM; Czernichow P
Pediatr Res; 1996 Jul; 40(1):101-7. PubMed ID: 8798254
[TBL] [Abstract][Full Text] [Related]
54. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.
Frystyk J; Ivarsen P; Skjaerbaek C; Flyvbjerg A; Pedersen EB; Orskov H
Kidney Int; 1999 Dec; 56(6):2076-84. PubMed ID: 10594783
[TBL] [Abstract][Full Text] [Related]
55. Serum insulin-like growth factor 1 and growth hormone levels of hypoxic-ischemic newborns.
Satar M; Ozcan K; Yapicioğlu H; Narli N
Biol Neonate; 2004; 85(1):15-20. PubMed ID: 14631161
[TBL] [Abstract][Full Text] [Related]
56. Serum insulin-like growth factor type 1, insulin-like growth factor-binding protein-1, and insulin-like growth factor-binding protein-3 concentrations in patients with thyroid dysfunction.
Iglesias P; Bayón C; Méndez J; Gancedo PG; Grande C; Diez JJ
Thyroid; 2001 Nov; 11(11):1043-8. PubMed ID: 11762714
[TBL] [Abstract][Full Text] [Related]
57. Acute stress response in children with meningococcal sepsis: important differences in the growth hormone/insulin-like growth factor I axis between nonsurvivors and survivors.
de Groof F; Joosten KF; Janssen JA; de Kleijn ED; Hazelzet JA; Hop WC; Uitterlinden P; van Doorn J; Hokken-Koelega AC
J Clin Endocrinol Metab; 2002 Jul; 87(7):3118-24. PubMed ID: 12107211
[TBL] [Abstract][Full Text] [Related]
58. Variations in biological and immunological activity of growth hormone during the neonatal period.
Pagani S; Chaler EA; Radetti G; Travaglino P; Meazza C; Bozzola E; Sessa N; Belgorosky A; Bozzola M
Horm Res; 2007; 68(3):145-9. PubMed ID: 17377396
[TBL] [Abstract][Full Text] [Related]
59. Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database).
Popovic V; Mattsson AF; Gaillard RC; Wilton P; Koltowska-Häggström M; Ranke MB
J Clin Endocrinol Metab; 2010 Sep; 95(9):4449-54. PubMed ID: 20610598
[TBL] [Abstract][Full Text] [Related]
60. Effect of acute elevation of IGF-I on circulating GH, TSH, insulin, IGF-II and IGFBP-3 levels in non-endocrine short stature (NESS).
Hanew K; Tanaka A
J Endocrinol Invest; 2001 Jan; 24(1):1-7. PubMed ID: 11227726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
